What is Diagens Biotechnology (HKG: 02526) worth?
$1.3Blast known valuation
Free account
See the evidence behind this price
- ·Watchlist + deal alerts for Diagens Biotechnology (HKG: 02526)
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for Diagens Biotechnology (HKG: 02526) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How Diagens Biotechnology (HKG: 02526)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Diagens Biotechnology (HKG: 02526), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Diagens Biotechnology (HKG: 02526) worth?
- Diagens Biotechnology (HKG: 02526)'s last known valuation is $1.3B.
- How much has Diagens Biotechnology (HKG: 02526) raised?
- Diagens Biotechnology (HKG: 02526) has raised $214.9M in total funding across its recorded rounds.